@article{article, title  = {{RO4 COST-EFFECTIVENESS ANALYSIS OF RFVIIIFC, PEGYLATED RFVIII, AND EMICIZUMAB FOR THE PROPHYLACTIC TREATMENT OF SEVERE HEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN THE UNITED STATES}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2019}},

 month = {{5}},

 author = {{Li N and Bullement A and McMordie S and Hatswell AJ and Wilson K}},

 doi = {{10.1016/j.jval.2019.04.1898}},

 volume = {{22}},

 journal = {{Value in Health}},

 pages = {{S389-S389}},

 note = {{Accessed on 2025/03/11}}}